3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
19
Prostatic Neoplasms
9
Polycystic Ovary Syndrome
7
Vitamin D Deficiency
6
Osteoporosis
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
4
Colonic Neoplasms
4
Obesity
3
Inflammation
3
Colorectal Neoplasms
3
Bone Diseases, Metabolic
3
Neoplasm Metastasis
2
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Lung Neoplasms
2
Leukemia
2
Gastrointestinal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Cancers
1
Interventions
Paclitaxel
10
Surveys and Questionnaires
6
Cisplatin
6
Carboplatin
5
pembrolizumab
4
Brachytherapy
4
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
Doxorubicin
3
Docetaxel
3
olaparib
2
niraparib
2
durvalumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Music Therapy
2
Mitomycin
2
Letrozole
2
Imagery, Psychotherapy
2
Hysterectomy
2
Exercise
2
Everolimus
2
Blood Specimen Collection
2
ulipristal acetate
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Neoplasms
×
Vitamin D
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled